Podcasts:

PLAYLIST TIME:

Latest News for: 2108

Edit

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

Nasdaq Globe Newswire 09 Apr 2025
Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerability of PALI-2108 ... .
  • 1
×